Sex differences in the association between spousal metabolic risk factors with incidence of type 2 diabetes: a longitudinal study of the Iranian population.


Journal

Biology of sex differences
ISSN: 2042-6410
Titre abrégé: Biol Sex Differ
Pays: England
ID NLM: 101548963

Informations de publication

Date de publication:
22 08 2019
Historique:
received: 18 05 2019
accepted: 12 08 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 11 2 2020
Statut: epublish

Résumé

We investigated whether metabolic risk factors in one spouse were associated with an excessive risk of type 2 diabetes in the other. The study cohort (1999-2018) included 1833 men and 1952 women, aged ≥ 20 years with information on both their own and their spouse's diabetes status and metabolic risk factors including body mass index (BMI), waist circumference, systolic and diastolic blood pressure, triglyceride to high-density lipoprotein cholesterol ratio, and type 2 diabetes. The associations between spousal metabolic risk factors and type 2 diabetes were estimated using Cox regression models adjusted for the three nested sets of covariates. We found 714 (360 men and 354 women) incident cases of type 2 diabetes, after more than 15 years of follow-up. Among women, having a husband with diabetes was associated with a 38% (hazard ratio (HR) 1.38; 95% confidence interval (CI) 1.03, 1. 84) increased risk of type 2 diabetes, adjusted for age, socioeconomic status, individual's own value of the respective spousal exposure variable, family history of diabetes, and physical activity level. After further adjustment for the woman's own BMI level, the husband's diabetes was associated with 23% (HR 1.23; 0.92, 1.64) higher risk of type 2 diabetes in wives, values which did not reach statistical significance. No significant associations were found between spousal metabolic risk factors and incidence of type 2 diabetes among index men. We found a sex-specific effect of spousal diabetes on the risk of type 2 diabetes. Having a husband with diabetes increased an individual's risk of type 2 diabetes. Our results might contribute to the early detection of individuals at high risk of developing type 2 diabetes, particularly, in women adversely affected by their partner's diabetes.

Sections du résumé

BACKGROUND
We investigated whether metabolic risk factors in one spouse were associated with an excessive risk of type 2 diabetes in the other.
METHODS
The study cohort (1999-2018) included 1833 men and 1952 women, aged ≥ 20 years with information on both their own and their spouse's diabetes status and metabolic risk factors including body mass index (BMI), waist circumference, systolic and diastolic blood pressure, triglyceride to high-density lipoprotein cholesterol ratio, and type 2 diabetes. The associations between spousal metabolic risk factors and type 2 diabetes were estimated using Cox regression models adjusted for the three nested sets of covariates.
RESULTS
We found 714 (360 men and 354 women) incident cases of type 2 diabetes, after more than 15 years of follow-up. Among women, having a husband with diabetes was associated with a 38% (hazard ratio (HR) 1.38; 95% confidence interval (CI) 1.03, 1. 84) increased risk of type 2 diabetes, adjusted for age, socioeconomic status, individual's own value of the respective spousal exposure variable, family history of diabetes, and physical activity level. After further adjustment for the woman's own BMI level, the husband's diabetes was associated with 23% (HR 1.23; 0.92, 1.64) higher risk of type 2 diabetes in wives, values which did not reach statistical significance. No significant associations were found between spousal metabolic risk factors and incidence of type 2 diabetes among index men.
CONCLUSION
We found a sex-specific effect of spousal diabetes on the risk of type 2 diabetes. Having a husband with diabetes increased an individual's risk of type 2 diabetes. Our results might contribute to the early detection of individuals at high risk of developing type 2 diabetes, particularly, in women adversely affected by their partner's diabetes.

Identifiants

pubmed: 31439024
doi: 10.1186/s13293-019-0255-5
pii: 10.1186/s13293-019-0255-5
pmc: PMC6704543
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41

Références

Trials. 2009 Jan 25;10:5
pubmed: 19166627
BMC Med. 2014 Jan 24;12:12
pubmed: 24460622
World J Diabetes. 2013 Aug 15;4(4):114-23
pubmed: 23961321
Int J Community Based Nurs Midwifery. 2017 Apr;5(2):196-204
pubmed: 28409173
BMC Med. 2017 Jul 19;15(1):131
pubmed: 28720102
BMJ. 2010 Aug 18;341:c4229
pubmed: 20724400
Eur J Epidemiol. 2015 Jul;30(7):529-42
pubmed: 26092138
Arch Iran Med. 2012 May;15(5):279-82
pubmed: 22519376
J Clin Hypertens (Greenwich). 2017 Nov;19(11):1088-1095
pubmed: 28856830
Annu Rev Clin Psychol. 2017 May 8;13:421-443
pubmed: 28301763
Prev Med. 2017 Dec;105:52-57
pubmed: 28823754
Nat Commun. 2018 Jul 27;9(1):2941
pubmed: 30054458
Diabetes Care. 2010 Feb;33(2):293-7
pubmed: 19903751
Diabetes Care. 2017 Jan;40(Suppl 1):S11-S24
pubmed: 27979889
Diabetologia. 2018 Jul;61(7):1572-1580
pubmed: 29520580
JMIR Res Protoc. 2017 Feb 23;6(2):e28
pubmed: 28232301
Acta Diabetol. 2019 Jun;56(6):619-629
pubmed: 30888538
BMJ. 2007 Sep 8;335(7618):481-5
pubmed: 17823190
Ann Epidemiol. 2006 Apr;16(4):285-91
pubmed: 16257231
Int J Endocrinol Metab. 2018 Oct 16;16(4 Suppl):e84784
pubmed: 30584445
JAMA Intern Med. 2015 Mar;175(3):385-92
pubmed: 25599511
BMC Psychiatry. 2017 May 19;17(1):190
pubmed: 28526002
Soc Sci Med. 2007 Jun;64(11):2297-310
pubmed: 17374552
Lancet. 2014 Jun 7;383(9933):1947-8
pubmed: 24910221
Diabetes Care. 2007 Mar;30(3):744-52
pubmed: 17327354
J Gen Intern Med. 2016 Oct;31(10):1127-33
pubmed: 27145760

Auteurs

Azra Ramezankhani (A)

Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Kamran Guity (K)

Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Fereidoun Azizi (F)

Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Farzad Hadaegh (F)

Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. fzhadaegh@endocrine.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH